Archive - October 2021
A right-first-time approach to development
UK doctors: Renewed COVID response is urgent
Pfizer-BioNTech booster offers 95.6% efficacy against COVID-19
US COVID-19 booster programme expanded
US approval for J&J and Moderna COVID-19 boosters
Dupixent hits all endpoints in prurigo nodularis trial
CBD For Allergies: Here’s How It Helps Alleviate Symptoms
Biopharma outsourcing goes international